Immunosuppression in Human Tumor-host Interaction: Role of Cytokines and Alterations in Signal-transducing Molecules

Overview

Journal Springer Semin Immunopathol

Specialty Allergy & Immunology

Date 1996 Jan 1

PMID 8908702

Citations 9

Authors

R Kiessling

K Kono

M Petersson

K Wasserman

Affiliations

Soon will be listed here.

Citing Articles

Targeting microenvironment in cancer therapeutics.

Martin M, Wei H, Lu T Oncotarget. 2016; 7(32):52575-52583.

PMID: 27270649 PMC: 5239574. DOI: 10.18632/oncotarget.9824.

Gene Expression Profile of T-cell Receptors in the Synovium, Peripheral Blood, and Thymus during the Initial Phase of Collagen-induced Arthritis.

Kim J, Lim M, Sheen D, Kim C, Lee S, Park H Immune Netw. 2011; 11(5):258-67.

PMID: 22194709 PMC: 3243000. DOI: 10.4110/in.2011.11.5.258.

Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.

Yip W, Abdullah M, Yusoff S, Seow H Clin Exp Immunol. 2009; 155(3):412-22.

PMID: 19220831 PMC: 2669517. DOI: 10.1111/j.1365-2249.2008.03793.x.

The tumor microenvironment and its role in promoting tumor growth.

Whiteside T Oncogene. 2008; 27(45):5904-12.

PMID: 18836471 PMC: 3689267. DOI: 10.1038/onc.2008.271.

SPARC ameliorates ovarian cancer-associated inflammation.

Said N, Elmarakby A, Imig J, Fulton D, Motamed K Neoplasia. 2008; 10(10):1092-104.

PMID: 18813349 PMC: 2546586. DOI: 10.1593/neo.08672.

References

Mantovani A, Bottazzi B, Sozzani S, Peri G, Allavena P, Dong Q . Cytokine regulation of tumour-associated macrophages. Res Immunol. 1993; 144(4):280-3; discussion 294-8. DOI: 10.1016/0923-2494(93)80108-b. View

Elsasser-Beile U, von Kleist S, Fischer R, Monting J . Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls. J Clin Lab Anal. 1992; 6(5):311-4. DOI: 10.1002/jcla.1860060510. View

Clerici M, Stocks N, Zajac R, Boswell R, Lucey D, Via C . Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest. 1989; 84(6):1892-9. PMC: 304069. DOI: 10.1172/JCI114376. View

Vivier E, Rochet N, Kochan J, Presky D, Schlossman S, Anderson P . Structural similarity between Fc receptors and T cell receptors. Expression of the gamma-subunit of Fc epsilon RI in human T cells, natural killer cells and thymocytes. J Immunol. 1991; 147(12):4263-70. View

Salazar-Onfray F, Petersson M, Franksson L, Matsuda M, Blankenstein T, Karre K . IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. J Immunol. 1995; 154(12):6291-8. View

Richter G, Kruger-Krasagakes S, Hein G, Huls C, Schmitt E, DIAMANTSTEIN T . Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 1993; 53(18):4134-7. View

Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L . The origin and function of tumor-associated macrophages. Immunol Today. 1992; 13(7):265-70. DOI: 10.1016/0167-5699(92)90008-U. View

Chen Q, Daniel V, Maher D, Hersey P . Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer. 1994; 56(5):755-60. DOI: 10.1002/ijc.2910560524. View

Schoof D, Terashima Y, Peoples G, Goedegebuure P, Andrews J, Richie J . CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells. Cell Immunol. 1993; 150(1):114-23. DOI: 10.1006/cimm.1993.1183. View

10.

Malissen M, Gillet A, Rocha B, Trucy J, Vivier E, Boyer C . T cell development in mice lacking the CD3-zeta/eta gene. EMBO J. 1993; 12(11):4347-55. PMC: 413731. DOI: 10.1002/j.1460-2075.1993.tb06119.x. View

11.

Romeo C, Amiot M, Seed B . Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain. Cell. 1992; 68(5):889-97. DOI: 10.1016/0092-8674(92)90032-8. View

12.

Ghalib H, Piuvezam M, Skeiky Y, Siddig M, Hashim F, El-Hassan A . Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest. 1993; 92(1):324-9. PMC: 293600. DOI: 10.1172/JCI116570. View

13.

Salgame P, Abrams J, Clayberger C, Goldstein H, Convit J, Modlin R . Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991; 254(5029):279-82. DOI: 10.1126/science.254.5029.279. View

14.

Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H . Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res. 1993; 53(23):5610-2. View

15.

Irving B, Weiss A . The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell. 1991; 64(5):891-901. DOI: 10.1016/0092-8674(91)90314-o. View

16.

Roth C, Rochlitz C, Kourilsky P . Immune response against tumors. Adv Immunol. 1994; 57:281-351. DOI: 10.1016/s0065-2776(08)60675-6. View

17.

Maeurer M, Martin D, Castelli C, Elder E, Leder G, Storkus W . Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol Immunother. 1995; 41(2):111-21. PMC: 11037792. DOI: 10.1007/BF01527407. View

18.

Gastl G, Abrams J, Nanus D, Oosterkamp R, Silver J, Liu F . Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer. 1993; 55(1):96-101. DOI: 10.1002/ijc.2910550118. View

19.

Klausner R, Lippincott-Schwartz J, Bonifacino J . The T cell antigen receptor: insights into organelle biology. Annu Rev Cell Biol. 1990; 6:403-31. DOI: 10.1146/annurev.cb.06.110190.002155. View

20.

Michiel D, Oppenheim J . Cytokines as positive and negative regulators of tumor promotion and progression. Semin Cancer Biol. 1992; 3(1):3-15. View